Legend Biotech Corp financial data

Symbol
LEGN on Nasdaq
Location
Somerset, NJ
Fiscal year end
31 December
Latest financial report
20-F - Q4 2025 - 10 Mar 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 369,886,369 shares 0.7%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $414,700,000 USD 0.29%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $1,733,700,000 USD 3.8%
Liabilities $731,600,000 USD 16%